NOTCH1 and primary cutaneous T-cell non-Hodgkin lymphoma: In cutaneous T-cell lymphoma cell lines gemcitabine treatment induced Notch1 and its target gene expression, and Notch1 knockdown improved gemcitabine anti-proliferative efficiency [588].